text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "fibroblast/diseased-line-fibroblasts.aspx"

134 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "fibroblast/diseased-line-fibroblasts.aspx"

642 Documents found
  • Transfection Protocol for Mouse ESC - 96-well Shuttle™ Device
    Instructions of use for transfection of mouse embryonic stem cells with the P3 Primary Cell 96-well Nucleofector™ Kit
  • Genome Editing using Nucleofector™ Technology
    Technical Reference Guide providing a brief introduction to genome editing tools and technical tips for ZFN, TALEN or CRISPR delivery using the Nucleofector™ Technology
  • Risk assessement covid-19 Verviers
  • WI-38 Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of WI-38 cells with the Cell Line Nucleofector™ Kit R
  • 3T3-L1 pre-ad Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of undifferentiated 3T3-L1 with the Cell Line Nucleofector™ Kit V
  • IMR-90 Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of IMR-90 cells with the Cell Line Nucleofector™ Kit R
  • Lonza Celebrates the 30th Anniversary of Clonetics Products, the Pioneer of Primary Cells
    Lonza is pleased to announce that the Clonetics™ Primary Cells and Media product line is celebrating its 30th anniversary, supporting cell culture research.
  • Tech/Instruction sheet - Immo. Coronary Artery SMC
    Technical information and instruction sheet for CloneticsTM Immortalized Coronary Artery Smooth Muscle Cells
  • Instructions - HL-1™ Serum replacement
    Instructions for use of HL-1 serum-free replacement
  • Transfection Protocol for Mouse ESC - 4D-Nucleofector™ Device
    Instructions of use for transfection of mouse embryonic stem cells with the P3 Primary Cell 4D-Nucleofector™ X Kit
  • Webinar - Hepatocytes in the Drug Development Pipeline
    Overview of how primary hepatocytes are used in drug development
  • Advancing Research with Biologically Relevant Results
    Primary Cells and MediaCell Culture ReagentsMycoplasma Detection SystemTransfection TechnologyNucleic Acid and Protein Electrophoresis
  • Viable Cells - Proliferating Clonetics™ Cells Chart
  • Monitoring_of hMSC Differentiation
    Co-marketed scientific poster with Sistemic Monitoring_of hMSC Differentiation with Histo- or Biochemical Assays and miRNA Expression Analysis
  • T/C-28 a2 Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of T/C-28 a2 cells with the Cell Line Nucleofector™ Kit V
  • T/G HA-VSMC Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of T/G HA-VSMC cells with the Cell Line Nucleofector™ Kit V
  • COS-7 Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of COS -7cells with the Cell Line Nucleofector™ Kit R
  • Instructions - HL-1™ Chemically Defined, Serum-free Media
    Detailed instructions how to use HL-1™ Chemically Defined Serum-free Medium
  • Neonatal Rat Cardiac Myocytes in Culture Display Hypertrophy to Non-hemodynamic Factors
    White Paper
  • Functional Assay of Neural Activity with Cell-Based Neural Culture Models and Microelectrode Array Technology for Proconvulsant Risk Assessment in the Neutox Pilot Study
    Lonza and Axion Biosystems’ poster from the 2019 SOT meeting discussing the use of primary cortical cell models and microelectrode array (MEA) technology for neurotoxicology and safety pharmacology assessment applications.
  • 5
  • 6(current)
  • 7